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Abstract Regulatory authorities often require in vitro
testing on medical devices prior to approval. Current
standardized corrosion testing methods (ASTM F2129)
require testing in a non-physiologic, de-oxygenated solu-
tion for a pre-exposure time of B1 h; however, no corre-
lations between the prescribed simulated environment and
whole blood conditions have been elucidated. This study
compared open circuit potential (OCP), breakdown
potentials (Eb), Eb - OCP, and cyclic polarization curves
tested in vivo (OCP only) and in vitro in whole blood to
those tested in phosphate-buffered saline (PBS). Two oxide
thicknesses of Nitinol, two solution oxygen contents
(deaerated and aerated solutions), and two pre-exposure
durations (acute and chronic) were investigated. The
in vitro OCP in whole blood was not significantly different
than the in vivo OCP, suggesting that whole blood in vitro
can be used to determine baseline corrosion behavior of
medical implants. Eb - OCP tested per ASTM F2129 was
comparable to acute whole blood and was conservative
compared to chronic whole blood for both oxide thick-
nesses. However, OCP, Eb, and cyclic polarization curves
were not always comparable to whole blood. Testing in
aerated PBS achieved Eb, Eb - OCP, and cyclic polar-
ization curves that were comparable to or more
conservative than whole blood testing, regardless of pre-
exposure duration and oxide thickness.
Keywords NiTi\materials  Shape memory stents 
Corrosion  In vivo  Open circuit potential  Breakdown
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Introduction
In vitro testing is essential for gaining insight into the
performance of medical devices. Ideally, in vitro tests
closely represent the clinical performance of the device.
However, a poorly designed test may cause many hours of
unnecessary design iterations, testing, and regulatory
activities in an effort to interpret results which do not
adequately mimic clinical performance.
It is imperative to fully understand how in vitro results
correlate to in vivo results. Designing in vitro tests to
mimic chronic physiologic conditions is necessary, and
often the tests need to be run in a short amount of time.
However, interpretation of short-term results to predict
chronic conditions can be difficult. ASTM F2129 is a well
accepted in vitro corrosion test for metallic implants that
describes a 1–2 h test in a deaerated solution to assess
chronic corrosion resistance [1]; however, defining a clin-
ically relevant acceptance criterion has proven difficult and
controversial [2]. A clinically relevant acceptance criterion
for Nitinol (NiTi) is especially important, since there are
multitudes of ways to prepare the surface, which can dra-
matically affect the ASTM F2129 results.
To develop a clinically relevant acceptance criterion, the
open circuit potential (OCP or the rest potential) of the
sample in vivo must be understood. Several in vivo studies
have been performed on NiTi [3, 4]; however, the reported
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range of NiTi rest potentials was quite large (-330 mVSCE
to ?10 mVSCE), and the results were not directly compared
to in vitro results.
It has been previously recommended to set an accep-
tance criterion without consideration of the test sample
OCP [5, 6]. Specifically, it has been recommend that
Eb\ 300 mV is unacceptable, Eb between 300 and
600 mV is marginal, and Eb[ 600 mV is acceptable. It is
important to note that these recommendations were made
with consideration of only a few metallic alloys (316
stainless steel, cobalt chromium, titanium, and Nitinol).
The application of an absolute acceptance criterion for
breakdown potential is problematic, since the OCP is dif-
ferent for various metals and metallic surface finishes, and
varies with implant duration. Therefore, due to the wide
variety of OCPs, an absolute acceptance criterion related to
breakdown alone might not be appropriate for the medical
device industry.
An alternative to using absolute Eb as the acceptance
criterion is to evaluate the corrosion resistance using the
difference between breakdown and the open circuit
potential (Eb - OCP), which has been recommended pre-
viously [7–9]. This difference provides more information
about the device’s corrosion behavior and how much the
device OCP is able to deviate without inducing localized
corrosion (i.e., pitting and breakdown). The argument
against Eb - Er (where ASTM F2129 defines Er, rest
potential, as the OCP following B1 h deaerated pre-expo-
sure) has been that Er is measured in a non-physiologic
solution that is not representative of in vivo OCP. In vivo
OCP values are not well known, and can vary based on
immersion solution, oxygen content, immersion time, and
surface finish. Several studies have been performed to
understand how oxygen content and immersion time affect
OCP, Eb, and Eb - OCP [7, 8]; however, no direct corre-
lation with in vivo results has been reported.
Therefore, the aim of this study was to compare the
corrosion results of two different NiTi oxide thicknesses
tested in vivo (measuring short-term OCP only) and
in vitro in whole blood to the results in phosphate-buffered
saline (PBS). Additionally, this study investigated the
effect of oxygen content of the test solution and pre-ex-
posure time on OCP, Eb, and Eb - OCP.
Materials and Methods
Testing was conducted on two NiTi oxide thicknesses used
for medical devices: black oxide (BO), and electropolished
and passivated (EP). These surface finishes were chosen to
encompass the range of oxide thicknesses typically used
for NiTi medical devices. NiTi #1 (Fort Wayne Metals,
Fort Wayne, IN) with a black oxide finish was acquired in
the straight annealed condition, with a diameter of 0.02600.
NiTi #1 is better than or equal to the chemical composition
defined by ASTM F2063. The BO oxide thickness was
measured to be 670 A˚ using Auger electron spectroscopy
(Fig. 1a). For the EP processing, BO NiTi samples from
the same lot were electropolished and passivated. To
illustrate changes in breakdown potential due to testing
environment and pre-exposure time, a suboptimal elec-
tropolish exhibiting occasional breakdown was chosen for
EP so that breakdown would occur in a portion of samples
prior to Ev. The resulting oxide thickness was measured to
be 34 A˚ (Fig. 1b). All samples were rinsed with distilled
water (ASTM Type 1) and alcohol, and then dried prior to
sending to Evans Analytical Group (EAG) for Auger
testing and analysis.
Electrochemical corrosion testing was performed with
Gamry Reference 600 potentiostats. All potentials were
measured in reference to saturated calomel electrodes
(SCE). Gamry DC105 software was used to perform the
test.
BO and EP NiTi wires were tested in 4 different envi-
ronments: (1) in vivo arterial blood, (2) in vitro venous
whole blood, (3) in vitro aerated PBS, and (4) in vitro
deaerated PBS.
In Vivo Studies
For the in vivo studies, an ovine model was used. Anes-
thesia was induced, and heparin was administered between
100–200 IU/kg. Testing was approved under facility
approved IACUC. Exposed wire (2.1 cm2) was placed
within the animal, while the remainder of the wire was
masked off with a non-conductive resin (Miccrostop). The
wire was inserted through an 18 French sheath placed
within the aorta via femoral access. Bilateral femoral
arteries were accessed, allowing two wires to be tested
simultaneously. An elongated SCE was also placed within
the 18 French sheath, parallel to the test specimen. The tip
of the elongated SCE was placed near the wire, outside the
sheath. Placement was verified via fluoroscopy. The
potential difference between the elongated SCE and the in-
house standard SCE was verified to be within ±3 mV.
Bilateral BO and EP wires were tested, and the access
location was alternated with each new sample to eliminate
the potential variable effects of test location and animal.
The potential after 1 h was recorded as the OCP. Arterial
blood chemistries including pH, partial pressure of oxygen
(pO2), saturation of oxygen (sO2), hemoglobin (Hb), ionic
calcium concentration (iCa), chlorine concentration (Cl),
sodium concentration (Na), and potassium concentration
(K) were measured before and after each open circuit scan
using an Abaxis i-Stat blood analyzer (cartridges
CHEM8? and CG4?).
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In Vitro Studies
Samples were placed within a 1 L jacketed electrochemical
corrosion cell containing whole blood, deaerated PBS, or
aerated PBS. Samples were electrically connected to
stainless steel mandrels using a silver solder epoxy.
Miccrostop was applied to the sample/mandrel interface
and the cut ends of the sample. The exposed surface area of
the wire samples was 1.6 cm2. Heparinized bovine whole
blood (LAMPIRE Biological Laboratories, Inc., Pipers-
ville, PA) with 1X penicillin/streptomycin was used to
prevent bacterial growth. Ionic concentrations were mea-
sured from each blood lot. Oxygen concentration, oxygen
saturation, and pH were measured before and after each
test and daily blood exchanges. PBS [1] was either deaer-
ated (bubbled with nitrogen) or aerated (bubbled with
compressed laboratory air) and buffered to a pH of
7.4 ± 0.2. Test solutions were maintained at 37 C ±
1 C. Open circuits (or pre-exposures) were measured for
either 1 h (acute) or 200 h (chronic), which were moni-
tored discretely for a minimum of 1 h each day until the
end of the test. NiTi OCP has been reported to reach steady
state after 200 h [7, 8]; therefore, this was chosen to rep-
resent a chronic state. Table 1 shows the sample sizes for
each OCP test group.
For all in vitro studies, a cyclic polarization scan was
conducted following the open circuit (pre-exposure) delay.
Cyclic polarization testing followed ASTM F2129, except
for the experimental changes to the aeration and open
circuit duration. The forward and reverse scan rates were
1 mV/s. The cyclic polarization scan was started at the
OCP, and the Ev (vertex potential) was 1200 mV. Pitting of
the samples was confirmed using light microscopy of up to
925 magnification.
Pre-exposure solution, pre-exposure time, and scan
solution were investigated; specifically, samples were
assigned to eight different cyclic polarization experimental
groups (Table 2). Group 1 (acute) samples and Group 2
(chronic) samples were tested in heparinized bovine whole
blood. The natural oxygen content in the whole blood was
desired, eliminating the need to bubble the solution. Group
3 (acute) samples and Group 4 (chronic) samples were
tested in aerated PBS. Additionally, Group 5 (acute) and
Group 6 (chronic) samples were used to investigate the
effect of pre-exposure in aerated PBS prior to testing in
deaerated PBS, in which case the solution was deaerated
for 30 min with nitrogen prior to the scan. Finally, Group 7
(acute—the control group tested fully to ASTM F2129) and
Group 8 (chronic) samples were tested in deaerated PBS.
Data Analysis
Experimental groups were compared using the GLM pro-
cedure in SAS (Statistical Analysis Software, version 9.3)
with a least-square mean statement utilizing Tukey test
(a = 0.05). For groups with censored data (i.e., lack of
breakdown prior to reversing the scan), a Kaplan–Meier
survival curve (lifetest procedure in SAS) was used to
compare groups.
Results
Acute and Chronic Open Circuit Potential (OCP)
OCP following 1 h pre-exposure (acute) in solution for all
test environments is presented in Fig. 2. The OCP for acute
in vitro whole blood was not significantly different from
Fig. 1 Auger analysis of BO (a) and EP (b) oxide thicknesses resulting in thicknesses of 670 A˚ and 34 A˚, respectively
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the OCP for in vivo whole blood for both oxide thicknesses
(p = 0.0636 for BO, 0.9964 for EP). For the acute BO
groups, in vitro aerated and deaerated PBS were signifi-
cantly different from the whole blood groups (p\ 0.0001).
For the acute EP groups, only the aerated PBS group was
significantly different from the whole blood groups
(p\ 0.0001). Oxygen content influenced mean OCP for all
samples at 1 h (Fig. 3), though the effect was greater on
samples with thicker oxides. Therefore, depending on the
oxide thickness, testing in conditions performed per ASTM
F2129 (deaerated PBS for 1 h) might result in OCPs which
are not representative of in vivo OCPs.
OCPs after 200 h (chronic) compared to 1 h (acute)
OCPs are shown in Fig. 2. All potentials increased with
longer pre-exposure times, and all groups, except EP in
deaerated PBS, trended toward a similar potential
(11–58 mV). Therefore, even after 200 h, deaerated OCPs
were not representative of in vivo potentials for all oxide
Table 1 Open circuit
experimental groups
Surface finish Solution Number of samples tested
1 h open circuit 200 h open circuit
BO NiTi In vivo whole blood 8 N/A
In vitro whole blood 12 4
In vitro aerated PBS 32 16
In vitro deaerated PBS 16 8
EP NiTi In vivo whole blood 8 N/A
In vitro whole blood 12 4
In vitro aerated PBS 40 16
In vitro deaerated PBS 28 16
Table 2 Cyclic polarization experimental groups
Cyclic polarization
experimental group
Open circuit (OC) Polarization scan solution Sample size
Solution Duration (h) BO NiTi EP NiTi
1 In vitro whole blood 1 In vitro whole blood 8 8
2 200 4 4
3 In vitro aerated PBS 1 In vitro aerated PBS 8 11
4 200 8 7
5 In vitro aerated PBS 1 In vitro deaerated PBS 8 11
6 200 8 8
7 (control) In vitro deaerated PBS 1 In vitro deaerated PBS 8 11
8 200 7 7
Fig. 2 Acute and chronic open circuit potentials Fig. 3 Open circuit potential versus oxygen partial pressure
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thicknesses, whereas chronic-aerated OCPs were similar to
chronic whole blood OCPs for both oxide thicknesses
(p = 0.9976 and p = 0.7397).
Auger was performed on EP NiTi samples following 1
and 200 h in PBS to compare to the untested samples
(Figs. 4 and 5). All samples increased in oxide thickness
following testing, with the largest increase occurring in
aerated PBS following 200 h. This is consistent with
results reported previously, indicating that oxide changes
over time and increases corrosion resistance [10, 11].
Breakdown Potentials (Eb)
The results for Eb of all groups investigated are presented
in Fig. 6 using Kaplan–Meier survival curves to account
for censored data (i.e., the Ev was reached prior to break-
down). Representative cyclic polarization curves are pre-
sented in Fig. 7.
For both oxide thicknesses, Eb improved with longer
pre-exposure time. The acute BO samples exposed exclu-
sively to aerated solutions (pre-exposure and scan) were
Fig. 4 Percent increase in oxide thickness versus pre-exposure
duration of EP NiTi wires
Fig. 5 Auger analysis of EP oxide thicknesses following pre-exposure: acute aerated (a); acute deaerated (b); chronic aerated (c); chronic
deaerated (d)
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most similar to whole blood (p = 0.7774) (Figs. 6a and
7a). The Eb of chronic BO samples exposed exclusively to
deaerated solutions (pre-exposure and scan) and the sam-
ples exposed exclusively to aerated solutions were most
similar to the whole blood Eb (p = 0.9850 and p = 0.1439,
respectively) (Fig. 6c). Most importantly, the Eb occurring
after chronic immersion in whole blood was significantly
different than the control as tested per ASTM F2129 (1 h
deaerated pre-exposure with deaerated scan), p\ 0.0001.
For both acute and chronic EP experimental groups, no
significant difference in Eb was observed for the different
testing conditions (p = 0.2297 and p = 0.6482, respec-
tively). However, acute EP samples exposed exclusively to
aerated solutions had the most conservative (i.e., resulting
in the lowest Eb) breakdown survival curve (Fig. 6b).
Overall, fewer EP samples broke down after chronic pre-
exposure compared to acute pre-exposure (Fig. 6b and d).
It is also interesting to note that acute BO samples pre-
exposed to aerated solutions followed by a deaerated scan
were not significantly different than the samples exposed
exclusively to deaerated solutions (p = 0.9957, Figs. 6a
and 7a), whereas chronic BO samples pre-exposed to aer-
ated solutions followed by a deaerated scan were similar to
the samples exposed exclusively to aerated solutions
(p = 0.7786, Figs. 6c and 7c).
Difference Between Eb and OCP (Eb 2 OCP)
For both oxide thicknesses, Eb - OCP increased with pre-
exposure duration, Fig. 8. For Groups 5 and 6, OCPs were
taken after the aerated pre-exposure, prior to deaerating
with nitrogen to start the cyclic polarization scan.
The BO samples exposed exclusively to aerated solu-
tions were more conservative (i.e., resulting in a lower
Eb - OCP) than whole blood for both acute and chronic
time points (Fig. 8a and c). The Eb - OCP results for BO
samples exposed only to deaerated solutions were most
similar to whole blood for both acute and chronic durations
(Fig. 8a and c). However, acute cyclic polarization scans
for deaerated PBS and whole blood were noticeably
Fig. 6 Kaplan–Meier curves for Eb: acute BO (a); acute EP (b); chronic BO (c); chronic EP (d)
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different (Fig. 7a). Thus, in vivo conditions are not fully
represented with a 1 h deaerated pre-exposure with
deaerated scan, depending on oxide thickness.
For both acute and chronic EP experimental groups, no
significant difference between the potential difference
survival curves was observed for the different testing
conditions (p = 0.0580 and p = 0.6482, respectively). The
most conservative condition for acute EP Eb - OCP was
the aerated pre-exposure with an aerated scan.
A summary of results is presented in Table 3.
Discussion
The cyclic polarization testing standard for metallic devi-
ces (ASTM F2129) has been well received by regulatory
agencies as an acceptable test for corrosion resistance for
implant devices [1]. However, determination of an accep-
tance criterion has been a topic of much debate. The
standard states that the method is intentionally severe and
meant for comparison purposes only; however, an absolute
acceptance criterion for Eb has been proposed [5, 6]. The
standard defines a pre-exposure time B1 h; however, oxide
thicknesses have been found to change over time [10, 11],
which can potentially change the corrosion resistance.
Therefore, care must be taken when determining clinically
relevant acceptance criteria. Additionally, the standard
dictates that testing be conducted in a non-physiological
de-oxygenated solution, with the aim of producing a lower
Eb. However, blood and other body fluids are not anoxic
(typical arterial and venous oxygen partial pressure ranges
are 80–100 and 40–50 mmHg, respectively) [12]. Finally,
the corrosion standard for galvanic testing of medical
implants, ASTM F3044, states that testing should be per-
formed in an aerated solution and that the coupled potential
be compared to Eb as found in ASTM F2129; thus, further
confounding testing practices when comparing aerated
galvanic results to deaerated breakdown results [13].
Therefore, this study investigated the effect of oxygen
content and pre-exposure time on OCP, Eb, and Eb - OCP
for two different NiTi oxide thicknesses (BO and EP). Both
EP and BO samples were investigated since medical
devices with EP and BO oxide thicknesses are currently
available in the market. By analyzing two extremes in
oxide thicknesses, a better understanding of how test con-
ditions affect corrosion results for a broad range of NiTi
medical devices can be achieved. Samples were tested
in vivo (acute OCP only) and in vitro in whole blood to
Fig. 7 Representative cyclic polarization curves: acute BO (a); acute EP (b); chronic BO (c); chronic EP (d)
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generate baseline physiologic results to compare against
simulated fluid (aerated and deaerated PBS) results.
This study showed that both oxygen content and pre-
exposure time had a significant effect on the corrosion
behavior of NiTi, regardless of oxide thickness. Performing
testing in vivo allows full understanding of the physiologic
corrosion behavior. In this study, in vitro and in vivo whole
blood resulted in similar OCP. Although not investigated in
this study, it is expected that in vitro Eb and cyclic polar-
ization curves in whole blood would be similar to that
occurring in vivo. However, testing in whole blood alone is
undesirable, due to the number of samples needed to
establish reliability and the increased cost of testing. This
study determined that 1 h data in whole blood were more
conservative (i.e., lower Eb - OCP) than chronic data for
both BO and EP. Therefore, a reasonable compromise
might be to test a small sample size in whole blood for 1 h
to gain an understanding of the representative physiologic
corrosion behavior of the implant and compare those
results to larger scale testing performed in a simulated
solution.
Previous investigators have shown that Eb - OCP
remained constant or increased with time, suggesting that
1 h pre-exposure time was conservative [8]. This is in
agreement with the results obtained in this study. OCP, Eb,
and Eb - OCP improved with time for both oxide thick-
nesses and aerations.
For deaerated PBS testing conditions, Eb - OCP was
comparable to whole blood for both oxide thicknesses and
pre-exposure times. However, the actual values of OCP, Eb,
and the cyclic polarization curves were not always similar to
those obtained in whole blood. In fact, the chronic EP OCP
for deaerated PBS remained *200 mV more active than
whole blood, and the acute BO Eb for deaerated PBS was
found to be *250 mV more negative than whole blood.
Additionally, the cyclic polarization curves for acute
deaerated pre-exposure were very different than the curves
tested in whole blood, depending on the oxide thickness. The
Fig. 8 Kaplan–Meier curves for Eb - OCP: acute BO (a); acute EP (b); chronic BO (c); chronic EP (d)
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acute deaerated BO samples exhibited a passivation poten-
tial where no such behavior was observed in whole blood.
Therefore, testing in a deaerated environment may not fully
capture the physiologic corrosion behavior of the sample in a
physiologically relevant environment.
Aerated pre-exposure prior to performing the cyclic
polarization scan in a deaerated environment has been rec-
ommended previously and resulted in an increasedOCP and a
more conservative Eb - OCP than testing with a deaerated
pre-exposure [7]. Similarly, an increase in OCP and a con-
servative Eb - OCPwith aerated pre-exposure followed by a
deaerated scan were observed in this study. However, acute
aerated pre-exposure was not sufficient to prevent the OCP
from immediately becoming more active during the deaera-
tion of the solution with nitrogen (Fig. 9a), resulting in a
polarization scan starting at a more negative potential than the
recorded aerated OCP. This resulted in an extremely conser-
vative Eb - OCP value, in which some values were negative
(though corrosion was not observed during the open circuit).
Therefore, testing in a deaerated environment following1 hof
aerated pre-exposure produces potentially misleading results.
It was found that 200 h of pre-exposure in an aerated solution
was sufficient to reach a steady state such that theOCPwas not
influenced when nitrogen was introduced (Fig. 9b).
Furthermore, chronic-aerated pre-exposure followed by a
deaerated scan achieved a representative OCP and a conser-
vative Eb, resulting in a conservative Eb - OCP compared to
whole blood (*390 mV difference for BO). Therefore, a
chronic pre-exposure in an aerated environment prior to a
deaerated scan is a conservative testing option; however, it is
essential that the OCP reaches a steady state.
Samples were also evaluated in an aerated environment
following an aerated pre-exposure. For both oxide thick-
nesses, acute-aerated OCPsweremost comparable to chronic
physiologic OCP values. For both time points and oxide
thicknesses, aerated cyclic polarization curves and Eb were
similar to whole blood. Additionally, aerated Eb - OCP was
less than or equal to whole blood for both time points and
oxide thicknesses. Overall, corrosion properties (OCP, Eb,
and Eb - OCP) increased with time, indicating that acute
aerated testing is conservative compared to chronic pre-ex-
posure durations. However, increasing the pre-exposure
duration might be a useful option for determining actual
chronic corrosion properties. Additionally, testing in an aer-
ated environment allows for a direct comparison to galvanic
testing per ASTM F3044 [13]. Regardless of pre-exposure
duration, testing in an aerated environment following an
aerated pre-exposure is a viable and conservative option for
Table 3 Summary of results
Result Figure
Open circuit potentials (OCP)
In vitro whole blood OCP was not significantly different than in vivo OCP for both oxide thicknesses
(p = 0.0636 and p = 0.9964)
Figure 2
Control (ASTM F2129) OCP was significantly different than in vivo OCP, depending on oxide thickness
(p\ 0.0001 for BO)
Figure 2
All OCPs increased over time Figure 2
Chronic deaerated PBS samples were significantly different than chronic whole blood, depending on the oxide
thickness (p\ 0.0001 for EP)
Figure 2
Chronic-aerated PBS samples were not significantly different than chronic whole blood regardless of the oxide
thickness (p = 0.9976 and p = 0.7397)
Figure 2
Breakdown potentials (Eb)
All Eb improved over pre-exposure time Figure 6
Eb tested per ASTM F2129 were significantly different than Eb chronically submerged in whole blood depending
on oxide thickness (p\ 0.0001 for BO)
Figures 6 and 7
Aerated Eb B whole blood Eb for both oxide thicknesses and pre-exposure times, and had similar cyclic
polarization curves
Figures 6 and 7
Difference in Eb - OCP
All Eb - OCP values improved over pre-exposure time Figure 8
Acute pre-exposure to aerated PBS prior to testing in deaerated PBS resulted in negative Eb - OCP values with
no pitting observed during open circuit
Figures 8 and 9
Deaerated PBS and whole blood were comparable and the least conservative (i.e., the highest difference between
Eb and OCP) test conditions regardless of pre-exposure time and oxide thickness. However acute cyclic
polarization curves in deaerated PBS and whole blood were different, depending on oxide thickness
Figures 7 and 8
Aerated PBS was more conservative (i.e., the lower difference between Eb and OCP) than or comparable to
whole blood regardless of pre-exposure time and oxide thickness
Figure 8
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determining the physiologic corrosion behavior of NiTi
implants used for medical devices.
Conclusions
Whole blood can be used to perform in vitro testing to
determine baseline corrosion behavior of medical implants
and aid in acceptance criterion development. Eb - OCP
tested according to the conditions defined in ASTM F2129
was comparable to acute whole blood and is conservative
compared to chronic whole blood for both oxide thick-
nesses of NiTi. However, testing per the conditions in
ASTM F2129 resulted in OCP, Eb, and cyclic polarization
curves that were not always comparable to whole blood
depending on oxide thickness. A standardized corrosion
assessment method should not be dependent on metallic
surface finish. Pre-exposing and conducting the polariza-
tion scan in aerated PBS achieved Eb, Eb - OCP, and
cyclic polarization curves that were comparable to or more
conservative than whole blood testing, regardless of pre-
exposure duration and oxide thickness. Testing in aerated
PBS also allows direct comparison to coupled galvanic
potentials measured using the methods in ASTM F3044.
Thus, testing in aerated PBS provides a more conservative
and complete assessment of corrosion resistance of
metallic medical implants.
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